Panitumumab Colorectal For Solution For Infusion

Product Description

1. What is Panitumumab?Panitumumab is a monoclonal antibody medication used in the treatment of colorectal cancer.

2. How does Panitumumab work?Panitumumab works by targeting and binding to a specific protein called the epidermal growth factor receptor (EGFR), which is found on the surface of some cancer cells. By blocking the activity of EGFR, Panitumumab helps slow down or stop the growth of cancer cells.

3. What conditions does Panitumumab treat?Panitumumab is used in the treatment of metastatic colorectal cancer that has not responded to other treatments, such as chemotherapy containing fluoropyrimidine, oxaliplatin, and irinotecan.

4. How is Panitumumab administered?Panitumumab is administered as an intravenous infusion (into a vein) by a healthcare professional in a clinic or hospital setting. The infusion is typically given once every two weeks. The dosage and frequency of administration will be determined by the patient's specific condition and medical history.

5. What are the common side effects of Panitumumab?Common side effects of Panitumumab may include skin rash or acne-like rash, diarrhea, fatigue, nausea, abdominal pain, decreased appetite, and low magnesium levels. More severe side effects may include infusion reactions, severe skin reactions, and electrolyte imbalances.

6. Who should not take Panitumumab?Panitumumab may not be suitable for everyone. Patients with certain medical conditions, such as a history of severe allergic reactions to monoclonal antibody medications or a history of interstitial lung disease, may not be able to take Panitumumab safely. It's crucial to inform your healthcare provider about your medical history and any medications you are currently taking before starting Panitumumab.

7. Is Panitumumab safe during pregnancy and breastfeeding?Panitumumab may cause harm to a developing fetus and is not recommended for use during pregnancy. It is also not known whether Panitumumab passes into breast milk, so breastfeeding is typically not recommended while receiving treatment with Panitumumab. It's essential to discuss the risks and benefits with your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding.

8. Are there any interactions with other medications?Panitumumab may interact with other medications, including other cancer treatments and medications that affect the immune system. It's crucial to inform your healthcare provider about all medications you are taking, including prescription drugs, over-the-counter medications, vitamins, and supplements, to avoid potential interactions.